Multinational evaluation of the interpretability of the iterative method of optimisation of AV delay for CRT

International Journal of Cardiology

Volumn 168, Issue 1, 2013, Pages 407-413

  Raphael, Claire E ^a   Kyriacou, Andreas ^b   Jones, Siana ^b   Pabari, Punam ^b   Cole, Graham ^b   Baruah, Resham ^b   Hughes, Alun D ^b   Francis, Darrel P ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

AV optimisation; Biventricular pacemaker; Cardiac resynchronisation; CRT; Iterative; SMART AV

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EPLERENONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SPIRONOLACTONE; WARFARIN;

ADULT; AGED; ARTICLE; ATRIOVENTRICULAR DELAY; ATRIOVENTRICULAR DISSOCIATION; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; HUMAN; IMAGE ACQUISITION; IMAGE ANALYSIS; ITERATIVE METHOD; KAPPA STATISTICS; MALE; MATHEMATICAL ANALYSIS; MEDICAL SPECIALIST; PRIORITY JOURNAL; PROCESS OPTIMIZATION; TEST RETEST RELIABILITY; THERAPY DELAY;

ATRIOVENTRICULAR DELAY; AV DELAY; AV OPTIMISATION; BIVENTRICULAR PACEMAKER; CARDIAC RESYNCHRONISATION; CARDIAC RESYNCHRONISATION THERAPY; CRT; ITERATIVE; LEFT VENTRICLE; LV; SMART-AV;

AGED; ATRIOVENTRICULAR NODE; CARDIAC RESYNCHRONIZATION THERAPY; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; INTERNATIONALITY; MALE; MIDDLE AGED; TIME FACTORS;

EID: 84883781202     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.09.097     Document Type: Article

References (13)

1. J. Gorcsan III, T. Abraham, and D.A. Agler American Society of Echocardiography Dyssynchrony Writing Group. Echocardiography for cardiac resynchronization therapy: recommendations for performance and reporting - a report from the American Society of Echocardiography Dyssynchrony Writing Group endorsed by the Heart Rhythm Society J Am Soc Echocardiogr 21 2008 191 213
2. P.E. Vardas, A. Auricchio, and J.J. Blanc European Society of Cardiology; European Heart Rhythm Association. Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association Europace 9 2007 959 998
3. T. Stanton, N.M. Hawkins, K.J. Hogg, N.E. Goodfield, M.C. Petrie, and J.J. McMurray How should we optimize cardiac resynchronization therapy? Eur Heart J 29 2008 2458 2472
4. N. Kedia, K. Ng, and C. Apperson-Hansen Usefulness of atrioventricular delay optimization using Doppler assessment of mitral inflow in patients undergoing cardiac resynchronization therapy Am J Cardiol 98 2006 780 785
5. J.G. Cleland, J.C. Daubert, E. Erdmann, N. Freemantle, D. Gras, L. Kappenberger, and L. Tavazzi Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure NEJM 352 2005 1539 1549
6. K.A. Ellenbogen, M.R. Gold, and T.E. Meyer Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy Circulation 122 2010 2660 2668
7. P.A. Pabari, K. Willson, and B. Stegemann When is an optimization not an optimization? Evaluation of clinical implications of information content (signal-to-noise ratio) in optimization of cardiac resynchronization therapy, and how to measure and maximize it Heart Fail Rev 16 2011 May 277 290
8. J.R. Landis, and G.G. Koch An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers Biometrics 33 1977 363 374
9. M.R. Mehra, and B.H. Greenberg Cardiac resynchronization therapy: caveat medicus! J Am Coll Cardiol 43 2004 1145 1148
10. C. Linde, F. Gadler, L. Kappenberger, and L. Rydén Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy. PIC Study Group. Pacing In cardiomyopathy Am J Cardiol 83 1999 903 907
11. S.S. Martinovic, Z. Perisic, and D. Milic Echocardiographic assessment of acute hemodynamic response during optimization of resynchronization pace-maker using different pacing modalities and atrioventricular delays Int J Cardiol 147 2011 470 471
12. L.G. Allan, and H.M. Jenkins The judgment of contingency and the nature of the response alternatives Can J Psychol 34 1980 1 11
13. M. Shun-Shin, and D.P. Francis Why Are Some Studies of Cardiovascular Markers Unreliable? The Role of Measurement Variability and What an Aspiring Clinician Scientist Can Do Before It Is Too Late Prog Cardiovasc Dis 55 1 2012 14 24